UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions

Annals of oncology, 2018-05, Vol.29 (5), p.1130-1140

2018

Volltextzugriff (PDF)

Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer

Annals of oncology, 2018-09, Vol.29 (9), p.1980-1986

2018

Volltextzugriff (PDF)

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

Annals of oncology, 2011-05, Vol.22 (5), p.1071-1077

2011

Volltextzugriff (PDF)

The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium

Annals of oncology, 2016-08, Vol.27 (8), p.1619-1625

2016

Volltextzugriff (PDF)

Induction Chemotherapy Followed by Concurrent Chemoradiation Therapy Versus Concurrent Chemoradiation Therapy Upfront in Locally Advanced Oral Cavity Cancer: Systematic Review and Meta-Analysis of Individual Data

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.882-883

2016

Volltextzugriff (PDF)

Systemic Immunologic Effects of Definitive Radiation in Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.864-864

2016

Volltextzugriff (PDF)

FIERCE-HN: A Multicenter, Randomized, Placebo-Controlled, Phase 3 Study of Ficlatuzumab + Cetuximab in Pts W/ Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma (HNSCC)

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e734-e734

2024

Volltextzugriff (PDF)

FIERCE-HN: A Multicenter, Randomized, Placebo-controlled, Phase 3 Study of ficlatuzumab + cetuximab in pts w/ recurrent or Metastatic (R/M) HPV-negative Head and Neck Squamous Cell Carcinoma (HNSCC)

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e36-e36

2024

Volltextzugriff (PDF)

Variability in Outcome Based on Type of Concurrent Chemotherapy for Treatment of Squamous Cell Carcinoma of the Oropharynx

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.872-872

2016

Volltextzugriff (PDF)

Patient Immunosuppression and the Association With Cancer-Specific Outcomes After Treatment of Squamous Cell Carcinoma of the Oropharynx

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.913-913

2016

Volltextzugriff (PDF)

Patterns of Failure After Reirradiation (reRT) With Intensity Modulated Radiation Therapy (IMRT): Not Just a Local Issue

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E340-E340

2015

Volltextzugriff (PDF)

Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Methotrexate (MTX): LUX-Head & Neck 1 (LHN1)

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.868-869

2016

Volltextzugriff (PDF)

Toxicity and Survival After Reirradiation (reRT) With IMRT for Recurrent Squamous Cell Cancer of the Head and Neck (SCCHN)

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.506-506

2014

Volltextzugriff (PDF)

Zanzalintinib Plus Pembrolizumab Versus Pembrolizumab Alone In Patients with PD-L1 Positive Metastatic Head And Neck Squamous Cell Carcinoma (STELLAR-305): A Double-Blind, Randomized, Placebo-Controlled, Phase 2/3 Study

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e40-e41

2024

Volltextzugriff (PDF)

Salivary Gland Tumors Treated with Adjuvant Intensity Modulated Radiation with or without Concurrent Chemotherapy: A Recent Experience

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S457-S458

2010

Volltextzugriff (PDF)

XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e17-e18

2024

Volltextzugriff (PDF)

Development and Validation of a Deep Learning System with Tumor- and Patient-Centric Imaging Analysis to Improve Risk-Stratification in Oropharyngeal Cancer

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e804-e805

2024

Volltextzugriff (PDF)

Chemotherapy outcomes following immunotherapy failure in advanced squamous cell carcinoma of the head and neck

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1177-1178

2020

Volltextzugriff (PDF)

PIK-ing out an intermediate-risk subgroup in advanced adenoid cystic carcinoma

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1192-1192

2020

Volltextzugriff (PDF)

Pre- and Post-treatment Serum Cytokine Expression Signatures and Survival Outcomes in Patients with Head and Neck Squamous Cell Cancer on Anti-PD-1 Therapy

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e90-e90

2024

Volltextzugriff (PDF)

Prospective Study of Plasma Biomarker-Guided Surveillance of HPV-positive Oropharynx Cancer Using TTMV-HPV DNA: The SPHERE Study

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e50-e50

2024

Volltextzugriff (PDF)

A Phase 2 Clinical Trial of Pembrolizumab with Radiation Following Progression on anti-PD-1 Therapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e32-e32

2024

Volltextzugriff (PDF)

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Annals of oncology, 2017-10, Vol.28 (10), p.2526-2532

2017

Volltextzugriff (PDF)

Automated Sarcopenia Assessment and Outcomes in Head and Neck Cancer with Deep Learning Analysis of Cervical Neck Skeletal Muscle

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e623-e623

2023

Volltextzugriff (PDF)

Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study

Annals of oncology, 2022-08, Vol.33 (8), p.836-844

2022

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Kollektion

IngentaConnect
(45)
Elsevier ScienceDirect Journals Complete
(45)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(44)
EZB Electronic Journals Library
(15)
LWW Total
(14)
IngentaConnect Journals
(12)
MEDLINE
(11)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions

Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium

Induction Chemotherapy Followed by Concurrent Chemoradiation Therapy Versus Concurrent Chemoradiation Therapy Upfront in Locally Advanced Oral Cavity Cancer: Systematic Review and Meta-Analysis of Individual Data

Systemic Immunologic Effects of Definitive Radiation in Head and Neck Cancer

FIERCE-HN: A Multicenter, Randomized, Placebo-Controlled, Phase 3 Study of Ficlatuzumab + Cetuximab in Pts W/ Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma (HNSCC)

FIERCE-HN: A Multicenter, Randomized, Placebo-controlled, Phase 3 Study of ficlatuzumab + cetuximab in pts w/ recurrent or Metastatic (R/M) HPV-negative Head and Neck Squamous Cell Carcinoma (HNSCC)

Variability in Outcome Based on Type of Concurrent Chemotherapy for Treatment of Squamous Cell Carcinoma of the Oropharynx

Patient Immunosuppression and the Association With Cancer-Specific Outcomes After Treatment of Squamous Cell Carcinoma of the Oropharynx

Patterns of Failure After Reirradiation (reRT) With Intensity Modulated Radiation Therapy (IMRT): Not Just a Local Issue

Tumor Biomarker Association With Clinical Outcomes in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Patients (Pts) Treated With Afatinib Versus Methotrexate (MTX): LUX-Head & Neck 1 (LHN1)

Toxicity and Survival After Reirradiation (reRT) With IMRT for Recurrent Squamous Cell Cancer of the Head and Neck (SCCHN)

Zanzalintinib Plus Pembrolizumab Versus Pembrolizumab Alone In Patients with PD-L1 Positive Metastatic Head And Neck Squamous Cell Carcinoma (STELLAR-305): A Double-Blind, Randomized, Placebo-Controlled, Phase 2/3 Study

Salivary Gland Tumors Treated with Adjuvant Intensity Modulated Radiation with or without Concurrent Chemotherapy: A Recent Experience

XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)

Development and Validation of a Deep Learning System with Tumor- and Patient-Centric Imaging Analysis to Improve Risk-Stratification in Oropharyngeal Cancer

Chemotherapy outcomes following immunotherapy failure in advanced squamous cell carcinoma of the head and neck

PIK-ing out an intermediate-risk subgroup in advanced adenoid cystic carcinoma

Pre- and Post-treatment Serum Cytokine Expression Signatures and Survival Outcomes in Patients with Head and Neck Squamous Cell Cancer on Anti-PD-1 Therapy

Prospective Study of Plasma Biomarker-Guided Surveillance of HPV-positive Oropharynx Cancer Using TTMV-HPV DNA: The SPHERE Study

A Phase 2 Clinical Trial of Pembrolizumab with Radiation Following Progression on anti-PD-1 Therapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Automated Sarcopenia Assessment and Outcomes in Head and Neck Cancer with Deep Learning Analysis of Cervical Neck Skeletal Muscle

Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study

Suchergebnisse filtern